Jean L. Wright, M.D.
- American Board of Radiology-Radiation Oncology
- Radiation Oncology
- Assistant Professor of Radiation Oncology
Memorial Sloan-Kettering Cancer Center
Yale University School of Medicine, Greenwich Hospital
Columbia University, College of Physicians and Surgeons
Dr. Wright completed her undergraduate education at Brown University, and graduated from Columbia University Medical School in 2003. She completed her residency at Memorial Sloane-Kettering in New York in 2008, and was subsequently recruited by the University of Miami School of Medicine as an Assistant Professor. She is a member of several professional organizations including the American Association for Women Radiologists, American Society for Therapeutic Radiology and Oncology, and the Radiological Society of North America.
Dr. Wright specializes in the treatment of breast cancer and lung cancer. Her research interest in breast cancer focuses on the management of locally advanced disease, particularly on the role of radiation for patients who recieve chemotherapy prior to mastectomy (neoadjuvant chemotherapy). She is the Principal Investigator of on ongoing study assessing genetic predisposition to more severe skin reactions with radiation treatment in those patients who have radiation after mastectomy. She offers hypofractionated radiation (shorter courses of radiation) and partial breast irradiation to selected patients as well. She also offers specialized techniques for protecting the heart from radiation dose, including respiratory gating for left-sided breast cancer.
She also focuses on the implementation of new technologies for the treatment of lung cancer, including intensitymodulated radiation, image-guided and stereotactic radiation techniques, and respiratory gating, all of which are available at Sylvester Cancer Center. She has several lung cancer protocols open to eligible patients, and is the Principal Investigator of a study assessing a new radiation technique for lung cancer, consisting of a stereotactic "boost" on the Cyberknife followed by a course of standard doses of radiation with chemotherapy.